Stephanie Baluca, PHARMD
Pharmacist · Toppenish, WA
Stephanie Baluca, PHARMD is a pharmacist with a practice address in Toppenish, Washington, and NPI 1942852678, issued on Jul 12, 2019. Check the license with the Washington board that licenses this profession; the Medicare figures below come from public CMS files.
- Name
- Stephanie Baluca
- Credential
- PHARMD
- Primary taxonomy
- Pharmacist 183500000X
- Practice location
- 510 W 1St Ave, Toppenish, WA 98948
- Phone
- (509) 865-5600
- Enumerated
- Jul 12, 2019
- Entity
- Type 1 · individual
Also registered at 510 W 1St Ave
A shared address usually means a shared clinic or building; it does not show who employs whom.
- Aaron Anderson, D.O.Internal Medicine Physician1003057381
- Marilyn BerkoPediatrics Physician1164454526
- Mandeep Brar, M.D.Pediatrics Physician1548886583
- Alicia BritoCase Manager/Care Coordinator1861027104
- Sean Brown, PHARM.DPharmacist1982977492
- Shawn Burwell, MDObstetrics & Gynecology Physician1235246893
Verify Stephanie Baluca in five checks
- 1IdentityNPI record in CMS NPPESNPI lookupConfirmed in NPPES
- 2LicenseActive license and public ordersWhich Washington board licenses this professionCheck the board
- 3Other statesLicenses and actions elsewhereDocInfo (FSMB)Not checked
- 4ExclusionsMedicare and Medicaid bansHHS-OIG exclusion listNot checked
- 5CertificationBoard certificationABMS, AOA, NCCPA, AANPNot checked
5.5 times the Medicare Part D claims of the average pharmacist in 2024
700 Medicare Part D claims for 321 beneficiaries, against an average of 127 among the 28,933 providers of this specialty who prescribed in Part D.
Most prescribed
- Atorvastatin Calcium76 claims
- Lisinopril55 claims
- Metformin Hcl49 claims
- Amlodipine Besylate38 claims
- Losartan Potassium35 claims
- Tamsulosin Hcl23 claims
Source: CMS Medicare Part D Prescribers by Provider and Drug, 2024 (data.cms.gov). Part D covers prescriptions for Medicare patients only; drugs with fewer than 11 claims are not published.
29 pharmacist records list a Toppenish practice address
They are 29 of the 349 NPPES records with a Toppenish practice address, and 7,880 pharmacist records in Washington.
All 29 in Toppenish → All 7,880 in Washington → Every provider in Toppenish →
Other pharmacist records in Washington
- Steven AahlBothell, WA1477691137
- Jon Aal, RPHOlympia, WA1457753212
- Kenric Aalund-NelsonBellingham, WA1033944996
- Kevin Aardal, RXTRichland, WA1932810298
- Rania Abaza, PHARMDVancouver, WA1699660258
- Roomi Abbas, RPHKenmore, WA1457293292
- Marvin Abbott, PHARMACISTOlympia, WA1053550384
- Doaa Abdelazeez, RPHLynden, WA1184153074
- John AbdelmalekAberdeen, WA1881985133
- Shorooq AbdelqaderSeattle, WA1528638889
Common questions
What is Stephanie Baluca, PHARMD's NPI number?
Stephanie Baluca, PHARMD's National Provider Identifier (NPI) is 1942852678, issued on Jul 12, 2019. An NPI identifies a provider in billing; it is not a license.
Where is Stephanie Baluca, PHARMD located?
The NPPES record lists a practice address at 510 W 1St Ave, Toppenish, WA, 98948. Phone: (509) 865-5600. Providers update this record themselves, so call before visiting.
How can I verify Stephanie Baluca, PHARMD's license?
Search the Washington board that licenses this profession; the NPPES record confirms identity only.
How much does Stephanie Baluca, PHARMD prescribe under Medicare Part D?
In 2024, Stephanie Baluca, PHARMD had 700 Medicare Part D claims for 321 beneficiaries; the average among pharmacist prescribers was 127. Part D covers Medicare prescriptions only.
Source: CMS National Plan and Provider Enumeration System (NPPES), loaded Aug 27, 2026 (NPPES files on CMS.gov); NUCC Health Care Provider Taxonomy. Medicare files from data.cms.gov. An NPI identifies who bills; it is not a license.
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of Aug 27, 2026.